Impact of an APA Program on EFS in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line

Clinical trial NCT04670029 · RECRUITING

Trial details

NCT number: NCT04670029
Sponsor: Weprom
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2021-09-08
Primary completion: 2025-08-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.